Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. junior Avg
|
New words:
ABECMA, accessible, adulterated, agonist, Agriculture, alpha, ALX, Appellate, Armenia, Arrowhead, assemble, atezolizumab, attrition, autoleucel, awaiting, azacytidine, Azerbaijan, ballot, Bank, belonging, biomarker, bioresearch, Boehringer, border, Britain, bruising, Brukinsa, BSc, Calquence, Cambridge, Canary, cedazuridine, censure, cereblon, charity, Cheng, childcare, children, ciltacabtagene, CJEU, clearance, color, Colorado, combat, conflicting, consciously, constitutionality, Contemporaneously, COVID, CPRA, CRL, CTI, cytidine, Czech, deaminase, decade, decitabine, decree, defeat, demographic, Denovo, destination, discomfort, discrepancy, disinfecting, domestic, drew, dubbed, Eastern, easy, eCRF, eldercare, EloPd, emotional, enzastaurin, equitable, erasure, evidentiary, Evorpacept, extrapolate, fall, falsifying, fever, fifteenth, Florida, frontline, fusion, Gaza, geared, Geron, GlaxoWellcome, goodwill, gouging, Great, greatly, greyscale, haematopoietic, Hampshire, HCRP, heightened, heightening, hemoglobin, HMA, HMR, Honig, ID, idecabtagene, identification, IFN, imetelstat, immunochemotherapy, Immunomodulator, inconsistent, inevitable, Ingelheim, innate, INQOVI, INREBIC, intangible, interleukin, internship, involuntary, Ireland, IRT, itching, ivosidenib, JAK, JAKAFI, JAKi, Kazakhstan, killer, Korean, Kyrgyzstan, Legend, lemzoparlimab, Libo, licensure, ligase, lock, locked, loncastuximab, loosely, Luxembourg, Lynparza, mAb, maraleucel, MHRA, migration, mistake, MIT, modality, Molag, Moldova, momelotinib, MPH, navitoclax, night, nintedanib, nonpromotional, Occasionally, Oceania, OFEV, olaparib, Omicron, omission, outset, Overflow, pace, pacritinib, pain, parsaclisib, passionate, PDCO, pelabresib, pertinent, Peter, Pharm, PIP, plausible, postponed, Potomac, PPACA, PREA, preapproval, precursor, preemption, premarket, prognostic, proportionate, PSP, psychological, punishable, ransomware, RARA, recombinant, recommence, registry, reinforce, reinterpreted, remote, rescind, rescinded, reticulin, RTF, Rubraca, rucaparib, Russia, sabatolimab, safest, Sangmin, sanitizer, Sarclisa, Saskatchewan, score, Scotland, sense, Servier, Shield, SI, Sierra, SIP, Sloan, societal, Sohanya, Southern, SPC, Stafford, standing, statistician, Steering, stratification, Strip, strongest, student, Subtopic, sue, SVR, Switzerland, symptom, Tajikistan, Tamibarotene, tesirine, tie, Today, Toronto, traceability, transfusion, true, Turkey, Turkmenistan, tutoring, Ukraine, unblinding, uncured, undergraduate, Uzbekistan, vaccinated, vaccine, variant, Vermont, vicleucel, Virginia, watch, West, word, Zejula
Removed:
abdomen, adapt, adequacy, Amherst, amicably, antigen, apparent, apportioned, ASH, Asian, asin, Assistant, attach, attained, attempting, Bessemer, Beth, bipartisan, brain, Bristol, Cadillac, cellular, chairman, chimeric, Christopher, clinic, clinician, colorectal, computational, concurrent, consult, consumption, convertibility, count, counterfeit, couple, coupon, CRC, deacetylase, dedifferentiated, demonstration, discounted, dispensing, division, divorce, divorced, Dolsten, donut, doxorubicin, DSMB, dysgeusia, East, Eli, endorsement, enhanced, epilepsy, ESMO, ETASU, explain, extending, Farydak, fat, FDASIA, formulary, fostering, founding, GBM, gene, glioblastoma, GPCR, hematology, histone, hole, host, Idec, illegitimate, implanted, imposing, improving, INAD, Infinity, inflammation, infused, inhaled, injected, instilled, intolerability, involvement, IP, IPAB, jointly, Kezar, KING, Lilly, liposarcoma, liposomal, meant, mechanistic, melanoma, middle, Mikael, Millennium, Mine, modeling, necessity, neuroprotective, NHL, nondeductible, Ono, Onyx, oprozomib, orin, orinter, outlined, ovarian, overcoming, oversaw, panobinostat, PBEF, pharmacoeconomic, potency, poverty, precedent, preoccupied, Primiano, prostate, Proteolix, radiological, reaching, RECIST, recurrence, remeasured, replication, resubmission, revising, revoked, rheumatology, rulemaking, sarcoma, SEAL, separated, separation, session, shuttle, SLE, soft, Southeast, spare, spontaneously, stabilization, structure, supplement, syndrome, targeting, temozolomide, tenant, thousand, topline, toxin, tracing, trained, traumatic, unamortized, unresectable, Unresolved, vast, Verastem, VGPR, viral, waiting, willingly
Filing tables
Filing exhibits
Related press release
Associated KPTI transcripts
KPTI similar filings
Filing view
External links
Exhibit 21.1
Subsidiaries of Karyopharm Therapeutics Inc.
|
|
|
|
| Jurisdiction of Incorporation or Organization |
Karyopharm Securities Corp. |
| Massachusetts |
Karyopharm Europe GmbH |
| Germany |
Karyopharm Israel Ltd. |
| Israel |